{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:P39900",
      "entity_text" : "MMP12",
      "features" : [ {
        "to_base" : "N",
        "site" : 122,
        "feature_type" : "mutation",
        "evidence" : "N122S"
      } ],
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "pubchem:5362119",
      "entity_text" : "lisinopril",
      "entity_type" : "simple_chemical"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "For those having either MMP12 N122S AG or GG genotype, lisinopril treatment increased the risk of CHD, combined CHD, and combined CVD when compared to patients treated with chlorthalidone or a higher risk of CHD and ACM when compared to patients treated with amlodipine.",
  "reading_complete" : "2020-08-08T14:17:35Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-08T14:16:04Z",
  "trigger" : "increased",
  "evidence" : [ "MMP12 N122S AG or GG genotype, lisinopril treatment increased" ],
  "pmc_id" : "3160956",
  "score" : 0
}